ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 150 filers reported holding ANIKA THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $206,000 | -62.9% | 5,737 | -56.0% | 0.00% | -100.0% |
| Q3 2021 | $555,000 | 0.0% | 13,030 | +1.7% | 0.00% | 0.0% |
| Q2 2021 | $555,000 | +0.2% | 12,810 | -5.6% | 0.00% | 0.0% |
| Q1 2021 | $554,000 | +16.6% | 13,575 | +29.3% | 0.00% | 0.0% |
| Q4 2020 | $475,000 | +43.1% | 10,500 | +12.0% | 0.00% | 0.0% |
| Q3 2020 | $332,000 | -7.0% | 9,374 | -1.0% | 0.00% | 0.0% |
| Q2 2020 | $357,000 | -17.2% | 9,466 | -36.6% | 0.00% | 0.0% |
| Q1 2020 | $431,000 | -42.7% | 14,920 | +2.9% | 0.00% | -50.0% |
| Q4 2019 | $752,000 | -2.0% | 14,495 | +3.7% | 0.00% | 0.0% |
| Q3 2019 | $767,000 | +34.6% | 13,973 | -0.5% | 0.00% | +100.0% |
| Q2 2019 | $570,000 | +32.9% | 14,040 | -1.0% | 0.00% | 0.0% |
| Q1 2019 | $429,000 | +97.7% | 14,179 | +120.0% | 0.00% | 0.0% |
| Q4 2018 | $217,000 | -20.2% | 6,446 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $272,000 | +32.0% | 6,446 | 0.0% | 0.00% | – |
| Q2 2018 | $206,000 | -41.8% | 6,446 | -9.5% | 0.00% | -100.0% |
| Q1 2018 | $354,000 | -12.4% | 7,126 | -5.0% | 0.00% | 0.0% |
| Q4 2017 | $404,000 | -7.1% | 7,499 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $435,000 | +17.6% | 7,499 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $370,000 | -50.6% | 7,499 | -56.5% | 0.00% | -50.0% |
| Q1 2017 | $749,000 | -11.4% | 17,250 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $845,000 | +144.2% | 17,250 | +138.5% | 0.00% | +100.0% |
| Q3 2016 | $346,000 | -10.8% | 7,232 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $388,000 | +20.1% | 7,232 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $323,000 | +17.0% | 7,232 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $276,000 | +20.0% | 7,232 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $230,000 | -25.3% | 7,232 | -22.4% | 0.00% | 0.0% |
| Q2 2015 | $308,000 | -19.8% | 9,319 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $384,000 | +1.1% | 9,319 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $380,000 | +11.1% | 9,319 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $342,000 | -30.2% | 9,319 | -11.9% | 0.00% | 0.0% |
| Q2 2014 | $490,000 | -18.3% | 10,578 | -27.6% | 0.00% | 0.0% |
| Q1 2014 | $600,000 | +7.7% | 14,606 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $557,000 | +59.1% | 14,606 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $350,000 | +41.1% | 14,606 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $248,000 | – | 14,606 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 490,331 | $21,928,000 | 10.27% |
| CAPITAL MANAGEMENT CORP /VA | 211,660 | $9,465,000 | 3.66% |
| AMI ASSET MANAGEMENT CORP | 336,791 | $15,061,000 | 1.03% |
| Baltimore-Washington Financial Advisors, Inc. | 68,785 | $3,076,000 | 0.93% |
| Portolan Capital Management | 130,939 | $5,856,000 | 0.78% |
| Kalos Management, Inc. | 19,254 | $861,000 | 0.72% |
| DIKER MANAGEMENT LLC | 32,965 | $1,474,000 | 0.56% |
| THOMPSON SIEGEL & WALMSLEY LLC | 1,526,244 | $68,253,000 | 0.56% |
| NEW AMSTERDAM PARTNERS LLC/NY | 108,260 | $4,841,000 | 0.51% |
| Boston Trust Walden Corp | 493,780 | $22,082,000 | 0.38% |